先声药业(02096)午后涨超8%,截至发稿,涨7.87%,报10.96港元,成交额1.85亿港元。消息面上,三生制药PD-1双抗出海刷新纪录,国产创新药企业不断释放自身的创新价值。以近年全球BD交易最热门的ADC领域为例,先声药业在自研创新平台的技术支持下,针对CDH6、CDH17、ENPP3、EGFR/cMet等多个靶点布局研发了多款ADC新药,构建了由多个FIC/BIC组成的创新药矩阵,且...
Source Link先声药业(02096)午后涨超8%,截至发稿,涨7.87%,报10.96港元,成交额1.85亿港元。消息面上,三生制药PD-1双抗出海刷新纪录,国产创新药企业不断释放自身的创新价值。以近年全球BD交易最热门的ADC领域为例,先声药业在自研创新平台的技术支持下,针对CDH6、CDH17、ENPP3、EGFR/cMet等多个靶点布局研发了多款ADC新药,构建了由多个FIC/BIC组成的创新药矩阵,且...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.